Literature DB >> 29528437

Searching for a Serological Correlate of Protection for a CMV Vaccine.

M R Schleiss1.   

Abstract

Mesh：

Substances：

Year:  2018        PMID： 29528437      PMCID： PMC5972601          DOI： 10.1093/infdis/jiy104

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  21 in total

Review 1.  Cytomegalovirus Vaccines: Current Status and Future Prospects.

Authors:  K M Anderholm; C J Bierle; M R Schleiss
Journal:  Drugs       Date:  2016-11       Impact factor: 9.546

2.  Preclinical evaluations of peptide-conjugate vaccines targeting the antigenic domain-2 of glycoprotein B of human cytomegalovirus.

Authors:  Adam C Finnefrock; Daniel C Freed; Aimin Tang; Fengsheng Li; Xi He; Chengwei Wu; Debbie Nahas; Dai Wang; Tong-Ming Fu
Journal:  Hum Vaccin Immunother       Date:  2016-03-17       Impact factor: 3.452

3.  A high-affinity native human antibody neutralizes human cytomegalovirus infection of diverse cell types.

Authors:  Lawrence M Kauvar; Keyi Liu; Minha Park; Neal DeChene; Robert Stephenson; Edgar Tenorio; Stote L Ellsworth; Takako Tabata; Matthew Petitt; Mitsuru Tsuge; June Fang-Hoover; Stuart P Adler; Xiaohong Cui; Michael A McVoy; Lenore Pereira
Journal:  Antimicrob Agents Chemother       Date:  2014-12-22       Impact factor: 5.191

4.  Cell surface expression of human cytomegalovirus (HCMV) gp55-116 (gB): use of HCMV-recombinant vaccinia virus-infected cells in analysis of the human neutralizing antibody response.

Authors:  W J Britt; L Vugler; E J Butfiloski; E B Stephens
Journal:  J Virol       Date:  1990-03       Impact factor: 5.103

5.  Vaccine prevention of maternal cytomegalovirus infection.

Authors:  Robert F Pass; Changpin Zhang; Ashley Evans; Tina Simpson; William Andrews; Meei-Li Huang; Lawrence Corey; Janie Hill; Elizabeth Davis; Cynthia Flanigan; Gretchen Cloud
Journal:  N Engl J Med       Date:  2009-03-19       Impact factor: 91.245

6.  Safety and efficacy of a cytomegalovirus glycoprotein B (gB) vaccine in adolescent girls: A randomized clinical trial.

Authors:  David I Bernstein; Flor M Munoz; S Todd Callahan; Richard Rupp; Susan H Wootton; Kathryn M Edwards; Christine B Turley; Lawrence R Stanberry; Shital M Patel; Monica M Mcneal; Sylvie Pichon; Cyrille Amegashie; Abbie R Bellamy
Journal:  Vaccine       Date:  2015-12-02       Impact factor: 3.641

Review 7.  Viral infections in solid organ transplant recipients: novel updates and a review of the classics.

Authors:  Ghady Haidar; Nina Singh
Journal:  Curr Opin Infect Dis       Date:  2017-12       Impact factor: 4.915

8.  HCMV gB shares structural and functional properties with gB proteins from other herpesviruses.

Authors:  Sapna Sharma; Todd W Wisner; David C Johnson; Ekaterina E Heldwein
Journal:  Virology       Date:  2012-10-22       Impact factor: 3.616

9.  Crystal Structure of the Human Cytomegalovirus Glycoprotein B.

Authors:  Heidi G Burke; Ekaterina E Heldwein
Journal:  PLoS Pathog       Date:  2015-10-20       Impact factor: 6.823

10.  Epitope-Specific Humoral Responses to Human Cytomegalovirus Glycoprotein-B Vaccine With MF59: Anti-AD2 Levels Correlate With Protection From Viremia.

Authors:  Ilona Baraniak; Barbara Kropff; Gary R McLean; Sylvie Pichon; Fabienne Piras-Douce; Richard S B Milne; Colette Smith; Michael Mach; Paul D Griffiths; Matthew B Reeves
Journal:  J Infect Dis       Date:  2018-05-25       Impact factor: 5.226
View more
  4 in total

Review 1.  A fifty-year odyssey: prospects for a cytomegalovirus vaccine in transplant and congenital infection.

Authors:  Don Jeffrey Diamond; Corinna La Rosa; Flavia Chiuppesi; Heidi Contreras; Sanjeet Dadwal; Felix Wussow; Supriya Bautista; Ryotaro Nakamura; John A Zaia
Journal:  Expert Rev Vaccines       Date:  2018-10-03       Impact factor: 5.217

2.  Awareness of congenital cytomegalovirus and acceptance of maternal and newborn screening.

Authors:  Katie J Tastad; Mark R Schleiss; Sara M Lammert; Nicole E Basta
Journal:  PLoS One       Date:  2019-08-26       Impact factor: 3.240

3.  MVA-Vectored Pentameric Complex (PC) and gB Vaccines Improve Pregnancy Outcome after Guinea Pig CMV Challenge, but Only gB Vaccine Reduces Vertical Transmission.

Authors:  Heidi Contreras; Felix Wussow; Claudia Fernández-Alarcón; Craig Bierle; Jenny Nguyen; Don J Diamond; Mark R Schleiss
Journal:  Vaccines (Basel)       Date:  2019-11-14

4.  Antibody binding to native cytomegalovirus glycoprotein B predicts efficacy of the gB/MF59 vaccine in humans.

Authors:  Jennifer A Jenks; Cody S Nelson; Hunter K Roark; Matthew L Goodwin; Robert F Pass; David I Bernstein; Emmanuel B Walter; Kathryn M Edwards; Dai Wang; Tong-Ming Fu; Zhiqiang An; Cliburn Chan; Sallie R Permar
Journal:  Sci Transl Med       Date:  2020-11-04       Impact factor: 19.319
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.